Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03058003 · ClinicalTrials.gov registry record
Correlation Between Central Sensitization Inventory and Posturographic Data
A clinical trial of Central Nervous System Sensitization, sponsored by Caps Research Network.
- Completed
- Registry status
- 180
- Enrollment target
- 2
- Study locations
NCT03058003: Completed study of Central Nervous System Sensitization, sponsored by Caps Research Network.
NCT03058003 is a study of Central Nervous System Sensitization that has completed, run by Caps Research Network. The registered enrollment target is 180 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03058003, a study of Central Nervous System Sensitization, has completed, sponsored by Caps Research Network.
- COMPLETED
- Registry status
- 180 participants
- Enrollment target
- 2
- Study locations
Study Summary
To investigate the use of balance as a screening tool for Central Sensitization, a condition of the nervous system that is associated with the development and maintenance of chronic pain. This is done by comparing the scores of a gold standard screening tool (the Central Sensitization Inventory) with balance data.
Primary Outcome
The Stability Score (calculated as percentage ratio of the actual sway and the theoretical limit of stability) will be used to investigate if there is any difference between healthy controls and subjects affected by chronic pain. Statistical tools such t-tests and correlation coefficients will be used for assess if there is a difference between the two groups
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Posturography Evaluation
- OTHER Central Sensitization Inventory
Study Locations (2)
Georgia
- Innova Brain Rehabilitation - Marietta
Victoria
- Small Street Clinic - Hampton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2016-05 |
| Est. Completion | 2021-04 |
What the finished NCT03058003 record still lists
NCT03058003 is an observational study that tracks outcomes without assigning an intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Central Nervous System Sensitization appearing as the primary indexed condition, and to 2 interventions - of which Posturography Evaluation is the first listed.
NCT03058003 reports a single indexed study location in Georgia, Victoria.
Frequently Asked Questions
What is clinical trial NCT03058003 about?
NCT03058003 is a clinical study titled "Correlation Between Central Sensitization Inventory and Posturographic Data". To investigate the use of balance as a screening tool for Central Sensitization, a condition of the nervous system that is associated with the development and maintenance of chronic pain. This is done by comparing the scores of a gold standard screening tool (the Central Sensitization Inventory) wit...
What is the current status of trial NCT03058003?
This trial is currently completed. The enrollment target is 180 participants. The study started on 2016-05. Estimated completion is 2021-04.
What conditions does trial NCT03058003 study?
This clinical trial studies the following conditions: Central Nervous System Sensitization.
What interventions are being tested in trial NCT03058003?
The interventions under investigation include: Posturography Evaluation (DIAGNOSTIC_TEST), Central Sensitization Inventory (OTHER).
Who is sponsoring clinical trial NCT03058003?
This trial is sponsored by Caps Research Network, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03058003 being conducted?
This trial has 2 study locations across Georgia, Victoria. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia